cr semaglutide FDA Clears For Cardiac Risk Reduction in Diabetic Patients Post-Patent Semaglutide Boom: Generics Set

Semaglutide is the first drug approved by the Food and Drug Administration (FDA) for chronic weight management/weight loss since 2014 and is marketed under brand names such as Ozempic, Wegovy, and a few other names

For clinicians, researchers and anyone navigating the increasingly crowded space between pharmaceutical and botanical medicine, I think this is worth six minutes of your time

The stock has experienced dramatic price swings over the past year but has gone literally nowhere, up less than 1% as of this writing

Last reviewed: May 25, 2026 Last updated: May 25, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations